We are live on ! Find out more
Two Sigma Advisers

Two Sigma Advisers Portfolio holdings

AUM $51.4B
1-Year Est. Return 31.07%
This Fund
S&P 500
This Quarter Est. Return
+9.38%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$43.1B
AUM Growth
+$2.24B
Cap. Flow
-$849M
Cap. Flow %
-1.97%
Top 10 Hldgs %
11.85%
Holding
2,563
New
364
Increased
1,030
Reduced
917
Closed
227

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$245M
2
META icon
Meta Platforms (Facebook)
META
+$204M
3
EXC icon
Exelon
EXC
+$196M
4
SHW icon
Sherwin-Williams
SHW
+$182M
5
PFE icon
Pfizer
PFE
+$174M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$400M
2
FIS icon
Fidelity National Information Services
FIS
+$280M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$230M
4
NOW icon
ServiceNow
NOW
+$222M
5
NKE icon
Nike
NKE
+$198M

Sector Composition

Rank Sector Weight
1 Technology 16.65%
2 Healthcare 16.47%
3 Consumer Discretionary 15.27%
4 Industrials 11.92%
5 Financials 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DWSN icon
2301
Dawson Geophysical
DWSN
$155M
$35K ﹤0.01%
14,733
– –
TRIB
2302
Trinity Biotech
TRIB
$5.7M
$34K ﹤0.01%
219
– –
VBIV
2303
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$34K ﹤0.01%
+830
New +$18.2K
CRIS icon
2304
Curis
CRIS
$9.53M
$33K ﹤0.01%
48
– –
HDSN
2305
Hudson Technologies
HDSN
$267M
$33K ﹤0.01%
33,700
-2,500
-7% -$1.68K
PFX icon
2306
PhenixFIN
PFX
$33K ﹤0.01%
750
-115
-13% -$5.06K
STKL
2307
DELISTED
SunOpta
STKL
$32K ﹤0.01%
12,924
-4,200
-25% -$9.35K
VIRX
2308
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$31K ﹤0.01%
2,592
+2,060
+387% +$34.5K
NBRV
2309
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$31K ﹤0.01%
94
+5
+6% +$2.29K
FBRX icon
2310
Forte Biosciences
FBRX
$1.12B
$30K ﹤0.01%
+151
New +$34.2K
TRIL
2311
DELISTED
Trillium Therapeutics Inc.
TRIL
$30K ﹤0.01%
28,700
– –
TTPH
2312
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$30K ﹤0.01%
10,774
-2,100
-16% -$6.74K
LBY
2313
DELISTED
Libbey, Inc.
LBY
$30K ﹤0.01%
20,841
+500
+2% +$938
FINV
2314
FinVolution Group
FINV
$1.12B
$29K ﹤0.01%
10,788
-32,300
-75% -$85.6K
TGB
2315
Trekor Metals
TGB
$2.56B
$29K ﹤0.01%
61,000
-14,800
-20% -$6.25K
CARM
2316
DELISTED
Carisma Therapeutics
CARM
$28K ﹤0.01%
+1,352
New +$31.1K
OBE
2317
Obsidian Energy
OBE
$707M
$28K ﹤0.01%
39,271
– –
GAU
2318
Galiano Gold
GAU
$486M
$26K ﹤0.01%
27,800
-1,800
-6% -$1.6K
VHI icon
2319
Valhi
VHI
$385M
$25K ﹤0.01%
1,117
– –
MRNS
2320
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$24K ﹤0.01%
2,800
-575
-17% -$3.23K
JAKK icon
2321
Jakks Pacific
JAKK
$280M
$22K ﹤0.01%
2,175
-80
-4% -$710
INAP
2322
DELISTED
Internap Corporation
INAP
$22K ﹤0.01%
19,749
-4,250
-18% -$7.45K
FNJN
2323
DELISTED
Finjan Holdings, Inc.
FNJN
$21K ﹤0.01%
10,200
-2,300
-18% -$4.48K
RTW
2324
DELISTED
RTW Retailwinds, Inc.
RTW
$20K ﹤0.01%
25,200
-300
-1% -$378
RDGT
2325
Ridgetech Inc
RDGT
$1.12M
– –
0
– –
91 92
93
94 95

Similar funds

CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
Comerica Bank
Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return
CWM
CIBC World Markets New York $20.8B AUM
VRS
Virginia Retirement Systems Richmond, Virginia $16.8B AUM 25.91% 1-Year Est. Return
FAF
Första AP-fonden Stockholm, Sweden $16.8B AUM 29.64% 1-Year Est. Return
BGIM
Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return
CIM
CCLA Investment Management London, United Kingdom $6.23B AUM 5.02% 1-Year Est. Return
PPFA
Provida Pension Fund Administrator Las Condes, Santiago, Chile $5.78B AUM 21.16% 1-Year Est. Return

Two Sigma Advisers's Q4 2019 Portfolio in Review

As of Q4 2019, Two Sigma Advisers held 2,563 positions worth $43.1B, up 5.5% from $40.9B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Two Sigma Advisers's Q4 2019 filing shows 364 new, 1,030 increased, 917 reduced and 227 closed positions. Its largest new stake was Netflix: 5,465,000 shares worth $177M. The largest sale was Microsoft, an estimated $400M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Two Sigma Advisers's largest Q4 2019 buy was Netflix: 5,465,000 shares worth $177M.
  • Two Sigma Advisers added most to Merck in Q4 2019, an estimated $245M increase.
  • Two Sigma Advisers's biggest Q4 2019 reduction was Microsoft, cutting an estimated $400M.
  • Two Sigma Advisers fully exited Fidelity National Information Services in Q4 2019, selling an estimated $280M.
  • Two Sigma Advisers's ten largest holdings make up 12% of its $43.1B portfolio in Q4 2019.
  • Two Sigma Advisers opened 364 new positions and closed 227 in Q4 2019.
  • Two Sigma Advisers's portfolio value rose 5.5% quarter-over-quarter to $43.1B.

Based on Two Sigma Advisers's 13F filing for Q4 2019, filed 14 Feb 2020.